Filed: 2026-04-13 AccNo: 0001628280-26-024929 Size: 9 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Canton Barry
Filed:
2026-04-10
AccNo:
0001628280-26-024744
Size:
14 KB
发布时间04/10 21:01 UTC
首次发现04/10 21:06 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 531 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001628280-26-024744
Filing Date: 2026-04-10
Accepted: 2026-04-10 17:01:54
Documents: 1
Period of Report: 2026-04-07
Ginkgo Bioworks Holdings, Inc. ( Issuer ) CIK : 0001830214 (see all company filings) EIN. : 872652913 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | FORM 4 | wk-form4_1775854911.html | 4
1 | FORM 4 | wk-form4_1775854911.xml | 4
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇